ABMD - ABIOMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABIOMED's activity chart (see below) currently has 138 price targets and 104 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.38% with an average time for these price targets to be met of 147.37 days.

Most recent stock forecast was given by from on 02-Nov-2022.

Best performing analysts who are covering ABMD - ABIOMED:

Bruce Nudell Pito Chickering David Lewis Matt O'brien Raj Denhoy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 15-Jul-2022

$380

$-1.02 (-0.27%)

$235

3 years 10 months 15 days ago
(02-Nov-2022)

1/2 (50%)

$6.49 (1.74%)

36

Buy Since 18-Jun-2021

$388

$6.98 (1.83%)

$355

3 years 10 months 15 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Buy Since 22-Feb-2018

$380

$-1.02 (-0.27%)

$350

3 years 10 months 16 days ago
(01-Nov-2022)

24/41 (58.54%)

$2.18 (0.58%)

138

Buy Since 30-Jun-2021

$300

3 years 11 months 4 days ago
(13-Oct-2022)

1/3 (33.33%)

$57.23 (23.57%)

20

$330

$-47.78 (-12.65%)

4 years 5 months 11 days ago
(06-Apr-2022)

1/1 (100%)

$16.24 (5.18%)

209

Show more analysts

Please expand the browser size to see the chart

What is ABMD (ABIOMED) average time for price targets to be met?

On average it took 147 days for the stock forecasts to be reached, with an average price target met ratio of 67.38%.

Which analyst most recently updated their price target on ABMD (ABIOMED)?

Which analyst has the most public recommendations on ABMD (ABIOMED)?

has 0 price targets and 0 ratings on ABMD

Which analyst is the currently most bullish on ABMD (ABIOMED)?

Raj Denhoy with the highest potential upside of $43.98

Which analyst is the currently most reserved on ABMD (ABIOMED)?

Suraj Kalia with the lowest potential downside of -$301.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?